Company Japan Tissue Engineering Co., Ltd.

Equities

7774

JP3389610001

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-04-19 am EDT 5-day change 1st Jan Change
645 JPY -5.43% Intraday chart for Japan Tissue Engineering Co., Ltd. -10.91% +27.47%

Business Summary

Japan Tissue Engineering Co Ltd is a Japan-based company mainly engaged in regenerative medicine product business, regenerative medicine outsourcing business, and research and development support business. The Company operates through three segments. The Regenerative Medicine Product segment develops regenerative medicine products using tissue engineering, and manufactures and sells the products for medical institutions. The regenerative medicine products include autologous cultured epidermis JACE, and autologous cultured cartilage JACK. The Regenerative Medicine Outsourcing segment provides contract development and manufacturing organization (CDMO) services, contract research organization (CRO) services, consulting services, and contract manufacturing services for specific cell processed products. The Research and Development Support segment manufactures and sells human cultured tissues that apply advanced culture technology accumulated through the development of in-house products.

Number of employees: 215

Sales per Business

JPY in Million2022Weight2023Weight Delta
Regenerative Medicine Product
69.2 %
1,479 70.3 % 1,406 69.2 % -4.95%
Regenerative Medicine Contract
20.6 %
391 18.6 % 419 20.6 % +7.18%
Research and Development Support
10.2 %
233 11.1 % 207 10.2 % -11.13%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
100.0 %
2,103 100.0 % 2,032 100.0 % -3.38%

Managers

Managers TitleAgeSince
President 59 04-09-30
Chief Tech/Sci/R&D Officer - -
Compliance Officer 67 07-04-30
Chief Tech/Sci/R&D Officer 63 04-03-31
Director/Board Member - -
Director/Board Member 62 19-05-31
Director/Board Member 58 18-05-31
Director/Board Member 67 99-01-31
Comptroller/Controller/Auditor 70 08-05-31
Comptroller/Controller/Auditor 60 99-08-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 99-01-31
President 59 04-09-30
Chief Tech/Sci/R&D Officer 63 04-03-31
Comptroller/Controller/Auditor 60 99-08-31
Compliance Officer 67 07-04-30
Director/Board Member 69 17-05-31
Director/Board Member 59 20-06-24
Director/Board Member 62 19-05-31
Director/Board Member 48 20-06-24
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 40,610,200 11,331,098 ( 27.90 %) 246 ( 0.000606 %) 27.90 %

Shareholders

NameEquities%Valuation
23,439,173 57.72 % 106 M ¥
Nidek Co., Ltd.
10.41 %
4,227,200 10.41 % 19 M ¥
Yoko Maeda
0.8431 %
342,400 0.8431 % 2 M ¥
292,000 0.7190 % 1 M ¥
290,000 0.7141 % 1 M ¥
Japan Tissue Engineering Employee Stock Ownership Plan
0.5833 %
236,883 0.5833 % 1 M ¥
184,000 0.4531 % 830 368 ¥
95,500 0.2352 % 430 979 ¥
Simplex Asset Management Co., Ltd.
0.0251 %
10,199 0.0251 % 46 027 ¥
Sawakami Asset Management, Inc.
0.0153 %
6,200 0.0153 % 27 980 ¥

Holdings

NameEquities%Valuation
200 0.00% 903 $

Company contact information

Japan Tissue Engineering Co., Ltd.

6-209-1 Miyakitadori

443-0022, Gamagori

+

http://www.jpte.co.jp
address Japan Tissue Engineering Co., Ltd.(7774)
  1. Stock Market
  2. Equities
  3. 7774 Stock
  4. Company Japan Tissue Engineering Co., Ltd.